Abstract
Objective: To evaluate whether cognitive performance in adults with active methamphetamine use (MA-ACT) differs from cognitive performance in adults in remission from MA use disorder (MA-REM) and adults without a history of substance use disorder (CTLs). Method: MA-ACT (n = 36), MA-REM (n = 48), and CTLs (n = 62) completed the Neuropsychological Assessment Battery (NAB). Results: The MA-ACT group did not perform significantly worse than CTLs on any NAB Index. The MA-REM group performed significantly (p < 0.050) worse than CTLs on the NAB Memory Index. The MA-ACT group performed significantly better than CTLs and the MA-REM group on the Executive Functions Index. Conclusions: Some cognitive deficits are apparent during remission from MA use, but not during active use; this may result in clinical challenges for adults attempting to maintain recovery and continue with treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 599-610 |
Number of pages | 12 |
Journal | Journal of Clinical and Experimental Neuropsychology |
Volume | 43 |
Issue number | 6 |
DOIs | |
State | Published - 2021 |
Keywords
- Cognition
- addiction
- dependence
- neuropsychological
- stimulant
- substance use disorder
ASJC Scopus subject areas
- Clinical Neurology
- Neuropsychology and Physiological Psychology
- Neurology
- Clinical Psychology